Skip to main content
SpringerLink
Log in

Iron Status Screening in Individuals with Heart Failure Before Initiating Sodium-Glucose Cotransporter 2 Inhibitor Therapy: Is It Necessary?

  • Letter to the Editor
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. Packer M. SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism. Nature Reviews Cardiology. 2023;20(7):443–62.

    Article  CAS  PubMed  Google Scholar 

  2. Yang Z, Li T, Xian J, et al. SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF-2α signaling pathway in arrhythmogenic cardiomyopathy. The FASEB Journal. 2022;36(7):e22410.

    Article  CAS  PubMed  Google Scholar 

  3. Mazer CD, Hare GM, Connelly PW, et al. Effect of empagliflozin on erythropoietin levels, iron stores, and red blood cell morphology in patients with type 2 diabetes mellitus and coronary artery disease. Circulation. 2020;141(8):704–7.

    Article  PubMed  Google Scholar 

  4. Packer M. Potential interactions when prescribing SGLT2 inhibitors and intravenous iron in combination in heart failure. JACC Heart Fail. 2023;11(1):106–14. https://doi.org/10.1016/j.jchf.2022.10.004.

    Article  PubMed  Google Scholar 

  5. McDowell LA, Kudaravalli P, Sticco KL. Iron Overload. 2022 Apr 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. 

Download references

Acknowledgements

No funding to report.

Author information

Authors and Affiliations

  1. Institute of Anatomy, Faculty of Medicine, University of Belgrade, 4/2 Dr Subotica Street, Belgrade, Serbia

    Ana Cirovic & Aleksandar Cirovic

Authors
  1. Ana Cirovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aleksandar Cirovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization: An.C, A.C

Original draft-writing: An.C, A.C

Approval: An.C, A.C

Corresponding author

Correspondence to Aleksandar Cirovic.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cirovic, A., Cirovic, A. Iron Status Screening in Individuals with Heart Failure Before Initiating Sodium-Glucose Cotransporter 2 Inhibitor Therapy: Is It Necessary?. Cardiovasc Drugs Ther (2023). https://doi.org/10.1007/s10557-023-07498-1

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10557-023-07498-1

Search

Navigation